More broadly, GLP-1R, together with the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon receptor (GCGR), forms a central endocrine network regulating energy balance and insulin sensitivity, and their selective or combined modulation underpins modern pharmacological interventions against metabolic disorders [13]. This evidence concerns the gene GIPR and metabolic disease.